首页/数据集/Maternal viremia (plasma HIV RNA ≥1,000 copies/ml) at FACES-supported facilities between 2017 and 2021.

Maternal viremia (plasma HIV RNA ≥1,000 copies/ml) at FACES-supported facilities between 2017 and 2021.

NIAID Data Ecosystem2026-05-02 收录

数据链接：

https://figshare.com/articles/dataset/Maternal_viremia_plasma_HIV_RNA_1_000_copies_ml_at_FACES-supported_facilities_between_2017_and_2021_/26746570 数据链接链接失效反馈

官方服务：

资源简介：

Maternal viremia (plasma HIV RNA ≥1,000 copies/ml) at FACES-supported facilities between 2017 and 2021.

应用场景：

创建时间：

2024-08-15

HIV母婴传播

生物样本

Describes the characteristics of HIV-infected pregnant women and their HIV-exposed, uninfected children at clinical sites in Latin America, including the utilization of interventions related to decrea

DataCite Commons2022-11-15 更新70

Self-Reported Participation in PMTCT Activities among HIV-infected Mothers.

HIV母婴传播

干预措施依从性

1Caregiver report prior to ELISA testing.

Figshare2015-12-02 更新50

P3 Source Obstetrical Complications Information Dataset in NISDI Pediatric Latin American Countries Epidemiological Study: A Prospective, Observational Study of HIV-infected Children at Clinical Sites in Latin American Countries

HIV母婴传播

HIV临床监测

Source of information about obstetrical complications (Maternal Pregnancy and Delivery History CRF) Study Description Describes the demographic, clinical, immunologic, and virologic characteristics of

NIAID Data Ecosystem40

M11 Maternal Diagnoses Dataset in A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries

HIV母婴传播

妇幼临床干预

New, ongoing, or resolved maternal diagnoses at enrollment or since last study visit (Maternal Diagnoses CRF) Study Description Describes the characteristics of HIV-infected pregnant women and their H

NIAID Data Ecosystem50

Maternal diagnoses in A Phase IV Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Two Different Triple Antiretroviral Regimens in HIV Infected Women Initiated Between 28 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission

HIV母婴传播

抗逆转录病毒治疗

Maternal diagnoses dataset Study Description P1081 was a Phase IV multicenter, randomized, open-label trial comparing the virologic response, safety, and tolerability of raltegravir. The study populat

NIAID Data Ecosystem40

Maternal viremia (plasma HIV RNA ≥1,000 copies/ml) at FACES-supported facilities between 2017 and 2021.

资源简介：

相关数据集